Quantity | Value |
---|---|
Total number of trials | 70 |
Reporting days | 2 trials reported on day 14, 56 trials on day 28, 22 trials on day 42, one trial on day 45, one on day 56 |
MAP prevalence estimates (mean and range) | 25.9% (0.2%, 86.5%) |
Trials treating young children only (< 72 months) | 26 |
Total number of patients treated | 8616 |
Patients treated in each trial (mean and range) | 123 (23, 665) |
Total number of patients for whom treatment failed | 14 ETFs, 380 recrudescences (of which 219 were asymptomatic and 161 (42.4%) were symptomatic) |